Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection

Microbial Pathogenesis

Volumn 46, Issue 5, 2009, Pages 235-242

  Kyläniemi, Minna K ^a,b   Haveri, Anu ^c   Vuola, Jenni M ^c   Puolakkainen, Mirja ^c,d   Lahesmaa, Riitta ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b National Graduate School in Informational and Structural Biology   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Chlamydia pneumoniae; Infection model; Lymphocyte; Microarray

Indexed keywords

INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTE; LYMPHOID ORGAN; MEDIASTINUM LYMPH NODE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REINFECTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

CHLAMYDOPHILA PNEUMONIAE; MUS;

EID: 65049088240     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.01.006     Document Type: Article

References (38)

1. Kuo C.C., Jackson L.A., Campbell L.A., and Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8 (1995) 451-461
2. Ekman M.R., Grayston J.T., Visakorpi R., Kleemola M., Kuo C.C., and Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 17 (1993) 420-425
3. Hansbro P.M., Beagley K.W., Horvat J.C., and Gibson P.G. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 101 (2004) 193-210
4. Belland R.J., Ouellette S.P., Gieffers J., and Byrne G.I. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 6 (2004) 117-127
5. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2 (2004) 23-32
6. Penttila J.M., Anttila M., Puolakkainen M., Laurila A., Varkila K., Sarvas M., et al. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun 66 (1998) 5113-5118
7. Yang Z.P., Kuo C.C., and Grayston J.T. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun 61 (1993) 2037-2040
8. Kaukoranta-Tolvanen S.S., Laurila A.L., Saikku P., Leinonen M., Liesirova L., and Laitinen K. Experimental infection of Chlamydia pneumoniae in mice. Microb Pathog 15 (1993) 293-302
9. Penttila J.M., Anttila M., Varkila K., Puolakkainen M., Sarvas M., Makela P.H., et al. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology 97 (1999) 490-496
10. Rottenberg M.E., Gigliotti Rothfuchs A.C., Gigliotti D., Svanholm C., Bandholtz L., and Wigzell H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 162 (1999) 2829-2836
11. Rottenberg M.E., Gigliotti Rothfuchs A., Gigliotti D., Ceausu M., Une C., Levitsky V., et al. Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 164 (2000) 4812-4818
12. Vuola J.M., Puurula V., Anttila M., Makela P.H., and Rautonen N. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun 68 (2000) 960-964
13. Penttila J.M., Pyhala R., Sarvas M., and Rautonen N. Expansion of a novel pulmonary CD3(-) CD4(+) CD8(+) cell population in mice during Chlamydia pneumoniae infection. Infect Immun 66 (1998) 3290-3294
14. Elo L.L., Lahti L., Skottman H., Kylaniemi M., Lahesmaa R., and Aittokallio T. Integrating probe-level expression changes across generations of affymetrix arrays. Nucleic Acids Res 33 (2005) e193
15. Yang X., and Brunham R.C. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol 161 (1998) 1439-1446
16. Elkins K.L., Bosio C.M., and Rhinehart-Jones T.R. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun 67 (1999) 6002-6007
17. Coombes B.K., and Mahony J.B. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69 (2001) 1420-1427
18. Hess S., Peters J., Bartling G., Rheinheimer C., Hegde P., Magid-Slav M., et al. More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation. Cell Microbiol 5 (2003) 785-795
19. Eickhoff M., Thalmann J., Hess S., Martin M., Laue T., Kruppa J., et al. Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism. Infect Immun 75 (2007) 2853-2863
20. Shi Y., and Tokunaga O. Chlamydia pneumoniae (C. pneumoniae) infection upregulates atherosclerosis-related gene expression in human umbilical vein endothelial cells (HUVECs). Atherosclerosis 177 (2004) 245-253
21. Virok D., Loboda A., Kari L., Nebozhyn M., Chang C., Nichols C., et al. Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis 188 (2003) 1310-1321
22. Mannonen L., Nikula T., Haveri A., Reinikainen A., Vuola J.M., Lahesmaa R., et al. Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells. J Infect Dis 195 (2007) 212-219
23. Rodriguez N., Mages J., Dietrich H., Wantia N., Wagner H., Lang R., et al. MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol Genomics 30 (2007) 134-145
24. Alvesalo J., Greco D., Leinonen M., Raitila T., Vuorela P., and Auvinen P. Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy. J Infect Dis 197 (2008) 156-162
25. Jenner R.G., and Young R.A. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 3 (2005) 281-294
26. Lim W.C., and Chow V.T. Gene expression profiles of U937 human macrophages exposed to Chlamydophila pneumoniae and/or low density lipoprotein in five study models using differential display and real-time RT-PCR. Biochimie 88 (2006) 367-377
27. Nguyen T.T., Hu Y., Widney D.P., Mar R.A., and Smith J.B. Murine GBP-5, a new member of the murine guanylate-binding protein family, is coordinately regulated with other GBPs in vivo and in vitro. J Interferon Cytokine Res 22 (2002) 899-909
28. Saha S., and Rangarajan P.N. Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J Gen Virol 84 (2003) 1729-1735
29. Dorn A., Zhao H., Granberg F., Hosel M., Webb D., Svensson C., et al. Identification of specific cellular genes up-regulated late in adenovirus type 12 infection. J Virol 79 (2005) 2404-2412
30. Kim K.I., Malakhova O.A., Hoebe K., Yan M., Beutler B., and Zhang D.E. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling. J Immunol 175 (2005) 847-854
31. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., and Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441 (1998) 106-110
32. Malakhov M.P., Malakhova O.A., Kim K.I., Ritchie K.J., and Zhang D.E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277 (2002) 9976-9981
33. Malakhova O., Malakhov M., Hetherington C., and Zhang D.E. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 277 (2002) 14703-14711
34. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
35. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20 (2002) 323-370
36. Nakamura A., Mori Y., Hagiwara K., Suzuki T., Sakakibara T., Kikuchi T., et al. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 197 (2003) 669-674
37. Abe T., Tominaga Y., Kikuchi T., Watanabe A., Satoh K., Watanabe Y., et al. Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung. Am J Respir Crit Care Med 156 (1997) 1235-1240
38. Tammiruusu A., Haveri A., Pascolo S., Lahesmaa R., Stevanovic S., Rammensee H.G., et al. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice. Scand J Immunol 62 (2005) 131-139